Diabetes, Obesity and Metabolism

GLP-1 based therapies: differential effects on fasting and postprandial glucose
pp. 675-688(14)
Authors: Fineman, M.S.; Cirincione, B.B.; Maggs, D.; Diamant, M.

The timing of dialysis and kidney transplantation in type 1 diabetes
pp. 689-693(5)
Author: Pavlakis, M.

The effect of linagliptin on glycaemic control and tolerability in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
pp. 694-708(15)
Authors: Singh-Franco, D.; McLaughlin-Middlekauff, J.; Elrod, S.; Harrington, C.

Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomized, double-blind, placebo-controlled studies in subjects with type 2 diabetes
pp. 709-716(8)
Authors: Katz, L. B.; Gambale, J. J.; Rothenberg, P. L.; Vanapalli, S. R.; Vaccaro, N.; Xi, L.; Sarich, T. C.; Stein, P. P.

Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register
pp. 717-726(10)
Authors: Ekström, N.; Miftaraj, M.; Svensson, A. -M.; Andersson Sundell, K.; Cederholm, J.; Zethelius, B.; Gudbjörnsdottir, S.; Eliasson, B.

NPY modulates PYY function in the regulation of energy balance and glucose homeostasis
pp. 727-736(10)
Authors: Zhang, L.; Nguyen, A. D.; Lee, I.-C. J.; Yulyaningsih, E.; Riepler, S. J.; Stehrer, B.; Enriquez, R. F.; Lin, S.; Shi, Y.-C.; Baldock, P. A.; Sainsbury, A.; Herzog, H.

Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus
pp. 737-744(8)
Authors: Pan, C.; Xing, X.; Han, P.; Zheng, S.; Ma, J.; Liu, J.; Lv, X.; Lu, J.; Bader, G.; on behalf of all investigatorscr10a9,

Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week study
pp. 745-752(8)
Authors: Yoon, K. H.; Steinberg, H.; Teng, R.; Golm, G. T.; Lee, M.; O'Neill, E. A.; Kaufman, K. D.; Goldstein, B. J.

Microvascular blood flow responses to muscle contraction are not altered by high-fat feeding in rats
pp. 753-761(9)
Authors: St-Pierre, P.; Keith, L. J.; Richards, S. M.; Rattigan, S.; Keske, M. A.

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes—a review and meta analysis
pp. 762-767(6)
Authors: Deacon, C. F.; Mannucci, E.; Ahrén, B.

Exercise increases skeletal muscle GLUT4 gene expression in patients with type 2 diabetes
pp. 768-771(4)
Authors: Hussey, S. E.; McGee, S. L.; Garnham, A.; McConell, G. K.; Hargreaves, M.